Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 3099,"Pirici D, etal., Brain Pathol. 2017 Mar;27(2):169-180. doi: 10.1111/bpa.12384. Epub 2016 May 30.",cerebral cortex integrity trait,,RS:0002538,SHRSP/A3NCrl,male,308 days to 84 days,80,,CMO:0003499,percentage of study population developing cerebral beta-amyloid deposits during a period of time,,,,23,%,,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107916,control condition 3099,"Pirici D, etal., Brain Pathol. 2017 Mar;27(2):169-180. doi: 10.1111/bpa.12384. Epub 2016 May 30.",kidney integrity trait,,RS:0002538,SHRSP/A3NCrl,male,308 days to 98 days,80,,CMO:0003649,percentage of study population developing kidney tubulointerstitial damage during a period of time,,percentage of study population developing kidney tubulointerstitial damage during a period of time (CMO:0003649),,85,%,,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107919,control condition 3099,"Pirici D, etal., Brain Pathol. 2017 Mar;27(2):169-180. doi: 10.1111/bpa.12384. Epub 2016 May 30.",cerebral cortex integrity trait,,RS:0002538,SHRSP/A3NCrl,male,308 days to 84 days,62,,CMO:0003503,percentage of study population developing cerebral small perivascular bleeds and no beta-amyloid deposits during a period of time,,,,26,%,,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107922,control condition 3099,"Pirici D, etal., Brain Pathol. 2017 Mar;27(2):169-180. doi: 10.1111/bpa.12384. Epub 2016 May 30.",cerebral cortex integrity trait,,RS:0002538,SHRSP/A3NCrl,male,308 days to 84 days,80,,CMO:0003501,percentage of study population developing cerebral small vessel thrombosis and adjacent tissue infarction during a period of time,,,,9,%,,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107918,control condition 3099,"Pirici D, etal., Brain Pathol. 2017 Mar;27(2):169-180. doi: 10.1111/bpa.12384. Epub 2016 May 30.",cerebral cortex integrity trait,,RS:0002538,SHRSP/A3NCrl,male,308 days to 84 days,80,,CMO:0003500,percentage of study population developing cerebral small perivascular bleeds during a period of time,,,,33,%,,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107917,control condition 3099,"Pirici D, etal., Brain Pathol. 2017 Mar;27(2):169-180. doi: 10.1111/bpa.12384. Epub 2016 May 30.",kidney integrity trait,,RS:0002538,SHRSP/A3NCrl,male,308 days to 168 days,80,,CMO:0003504,percentage of study population developing renal vascular pathology during a period of time,,,,45,%,,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107920,control condition 3099,"Pirici D, etal., Brain Pathol. 2017 Mar;27(2):169-180. doi: 10.1111/bpa.12384. Epub 2016 May 30.",cerebral cortex integrity trait,,RS:0002538,SHRSP/A3NCrl,male,308 days to 84 days,18,,CMO:0003502,percentage of study population developing cerebral small perivascular bleeds and beta-amyloid deposits during a period of time,,,,56,%,,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107921,control condition